INTRODUCTION
Over 5,000 lithium poisonings were reported to US poison centers in 2003 [1] . Patients being evaluated for suspected drug overdose or toxicity routinely have serum drug levels drawn for medications that may require specific interventions (e.g. antidote therapy, extracorporeal removal). Although it seems intuitive that lithium heparin-containing tubes (LHT) would be inappropriate when measuring serum lithium levels, such tubes are frequently used in cases of suspected toxicity to measure serum concentrations of several different medications. Our toxicology service was recently consulted to aid in an emergency department case of suspected lithium intoxication in a 12-year-old patient after serum analysis demonstrated a toxic (9.2 mmol/L, normal 0.5-1.0) lithium level. In this case, the patient's lack of clinical signs and symptoms consistent with lithium toxicity did not correlate with the lithium level measured by our laboratory. Only after extensive clinical and laboratory evaluation was it determined that the lithium levels were falsely elevated due to LHT blood tubes. The delay to definitive diagnosis and potential for inappropriate invasive hemodialysis in this patient led us to perform a study to determine the variation in measured serum lithium levels that are a result of by tube type and volume of blood used.
MATERIALS AND METHODS
This descriptive study was performed to determine the contribution of lithium found in green top blood tubes to the reported serum lithium level. Institutional IRB approval was obtained. Two types of green top tubes-(1) Vacutainer® 13 × 75 mm (4 mL draw, light green top) with serum separator gel and 57 USP units of lithium, and (2) Vacutainer® 13 × 75 mm (5 mL draw, dark green top) with 72 USP units of lithium-were compared against a Vacutainer® serum separator tube (SST) that was used as a control. The control SSTs contained no lithium. Blood samples were obtained from 5 healthy volunteers who have never ingested lithium and who did not use pharmaceuticals, dietary supplements, vitamins, or illicit drugs. Blood samples were aliquoted in the following fashion: full-draw green top, 2cc, 1cc, and full-draw SST. Samples were analyzed using a Beckman Coulter Synchron-CX7 system, colorimetric assay. Data were collected and entered into an Excel (Microsoft Corp., Redmond, WA) database and were analyzed using descriptive statistics. Figure 1 displays the mean serum lithium levels by volume of blood used in each tube.
RESULTS
(gel) at full-draw, 2cc, and 1cc were 1.05 [1.0-1.1], 1.
DISCUSSION
Our study demonstrates that the type of blood tube they are drawn in significantly affects lithium levels. While lithium levels in control tubes were non-detectable, there was an inversely proportional increase in the mean lithium level with the volume of blood in LHTs. Although it makes sense that lithium levels should not be measured from lithium containing green-top-tubes, such green-top-tubes are commonly used during the routine evaluation of overdose patients to measure the serum concentrations of a number of different pharmaceuticals. Since nurses and technicians frequently do blood draws, physicians are often unaware of the types of tubes used when interpreting results reported from a laboratory. Safe and appropriate management decisions rely on accurate results, especially when interventions such as hemodialysis may contribute to morbidity in patients who do not need such interventions.
Falsely elevated lithium levels from LHT blood tubes have been reported in two previous case reports [2, 3] . Nordt and Cantrell reported a case of a 33-year-old woman with a multiple drug overdose. A falsely elevated lithium level was identified because of serum sampling in a lithium heparin tube [2] . In the case of multiple drug ingestion, detection of several drug levels was necessary and the single lithium heparin tube was convenient for all the levels except the lithium. Lee and Klachko described how an inaccurately high lithium level drawn in a lithium containing tube almost led to hemodialysis of a child 15-months of age [3] . Their case prompted them to perform a pilot study that demonstrated a measurable lithium level in serum collected in LHTs in non-lithium takers. Our study demonstrates that the vol- ume of serum in LHTs is another clinically important contributing factor to the magnitude of falsely elevated lithium levels in subjects without any lithium exposure. Tubes that are incompletely filled can add as much as 4 mmol/L to the reported level. Due to lithium containing blood tubes, lithium levels in those two reports ranged from 1.5-3.4 mmol/L. The volunteers in our study who did not take lithium demonstrated that the potential exists for a 1 mmol/L elevation from a full blood draw in a lithium containing tube and that increases of up to 4 mmol/L may result from the inadequate filling of tubes.
LIMITATIONS
Our study does not address to what degree lithium levels drawn in LHT impacts patients taking lithium either therapeutically or in overdose.
CONCLUSION
Falsely elevated lithium levels that suggest significant toxicity may occur when using lithium containing blood tubes. Although these tubes are appropriate for other assays, healthcare staff should be educated concerning the potential for diagnostic errors in cases where lithium toxicity is being evaluated.
